Although Kenvue did not break out sales for Band-Aid in its fourth-quarter earnings report, it listed it as one of its 15 “priority brands,” along with products such as Tylenol, Motrin and Listerine. In an aim to “reach more consumers” the company will put a “stronger focus” on the 15 brands, CEO Thibaut Mongon said during an earnings call.
Retail sales for first aid adhesive bandages have been on the rise in the U.S. In the 52 weeks ending on March 24, 2024, sales totaled $733 million at grocery, drug, mass market, convenience, military and select club and dollar retailers, according to Circana, a Chicago-based market research firm. That’s up 5.1% from the year ending Dec. 31, 2023, when sales totaled $728 million. And that year’s sales were up 4.8% from 2022 when sales totaled $695 million.
The Band-Aid campaign comes just a few weeks after the release of a report that from an independent lab that found organic fluorine—which studies say can indicate the presence of “forever chemicals,” which can be toxic—in Band-Aid and other adhesive bandage brand products. The report was commissioned by Environmental Health News and consumer watchdog Mamavation. “The health and safety of the people who use our products is our top priority. We are reviewing the conclusions outlined in the report and committed to using our science to ensure our products have the best quality ingredients,” a Kenvue spokesperson told Ad Age.